NT
Nexalis Therapeutics Limited Stock: price and insider trades · Australia
Nexalis Therapeutics Limited: what insiders have been doing
Nexalis Therapeutics Limited has a thin disclosure history in our data. New filings will appear here as soon as they are published. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
A$0.01
Analyst consensus
Income statement
RevenueA$24.8k
Gross profitA$24.8k100% margin
EBITDA-A$1.5M-5977% margin
Net income-A$1.6M-164.1% margin
Valuation
Beta0.18
Balance sheet & cash
Market capA$2.8M
Total debtA$741.3k
Free Cash Flow-A$888.2k
Profitability & ownership
ROA-86.7%
% insiders82.3%
% institutions0.0%
Declarations0 total
No declarations found
0 of 0 declarations
About Nexalis Therapeutics Limited
NX1 is a company listed on the Australian Securities Exchange, specializing in the technology sector. It focuses on developing innovative solutions for the market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
